The precise underlying mechanism is unknown, although anti-CD20 antibodies have been shown to counteract CD40-induced resistance in CLL cells in vitro irrespective of BCL-2 family member alterations [94]. This evidence concerns the gene CD40 and B-cell chronic lymphocytic leukemia.